Sibeprenlimab gains accelerated approval from the FDA for IgA nephropathy, showing significant proteinuria reduction and ...
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for ...
Organon and Henlius announce FDA approval of POHERDY, the first and only pertuzumab biosimilar in the US, which is ...